Similar articles

• Potential for overuse of corticosteroids and vasopressin in septic shock.

  Hsu JL, Liu V, Patterson AJ, Martin GS, Nicolls MR, Russell JA. Hsu JL, et al. Crit Care. 2012 Sep 6;16(5):447. doi: 10.1186/cc11460. Crit Care. 2012. PMID: 23102413 Free PMC article. No abstract available.
• Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock.

  Russell JA, Walley KR, Gordon AC, Cooper DJ, Hébert PC, Singer J, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ; Dieter Ayers for the Vasopressin and Septic Shock Trial Investigators. Russell JA, et al. Crit Care Med. 2009 Mar;37(3):811-8. doi: 10.1097/CCM.0b013e3181961ace. Crit Care Med. 2009. PMID: 19237882 Clinical Trial.
• Changes in vasopressin use and outcomes in surgical intensive care unit patients with septic shock.

  Lupei MI, Beilman GJ, Chipman JG, Mann HJ. Lupei MI, et al. Chirurgia (Bucur). 2009 Sep-Oct;104(5):575-81. Chirurgia (Bucur). 2009. PMID: 19943557
• A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: a meta-analytic/meta-regression study.

  Kumar A, Safdar N, Kethireddy S, Chateau D. Kumar A, et al. Crit Care Med. 2010 Aug;38(8):1651-64. doi: 10.1097/CCM.0b013e3181e96b91. Crit Care Med. 2010. PMID: 20562695 Review.
• The safety and efficacy of the use of vasopressin in sepsis and septic shock.

  Wilson SJ, Mehta SS, Bellamy MC. Wilson SJ, et al. Expert Opin Drug Saf. 2005 Nov;4(6):1027-39. doi: 10.1517/14740338.4.6.1027. Expert Opin Drug Saf. 2005. PMID: 16255662 Review.